Amarin Corp Plc (AMRN)

[north40000]

biopa, for some reason(relating to a “hidden identity”) I can’t respond directly to your most recent message. Suffice to say, I think if you trace my name and posts on the Amarin message board you will have my current assessment of where we shareholders and Amarin now stand. In short, I am more optimistic. I will have a better assessment after 1) the decision and opinion of the CAFC is released, and 2) Amarin’s posters and abstracts are presented this weekend, particularly Sunday’s poster that ACC says I need a meeting key to open and read. Maybe kiwi or exwannabe have a key and can open it to post the text. 3) I have not read the text and claims of the new patent to be granted by EU authorities either.

Meantime I suggest you read the article appearing at [e-mail]. Dew Diligence provides a link at post # 251995 on the Biotech Value board. Ask yourself: Does this article relate in any way to the Phase 3 BRAVE clinical trial that is examining the effect of Vascepa as a biomarkers diagnostic of dementia and AD?